Cargando…

Soluble CD137 Ameliorates Acute Type 1 Diabetes by Inducing T Cell Anergy

We show here that soluble CD137 (sCD137), the alternately spliced gene product of Tnfsfr9, effectively treats acute type 1 diabetes (T1D) in nonobese diabetic (NOD) mice. sCD137 significantly delayed development of end-stage disease, preserved insulin+ islet beta cells, and prevented progression to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Itoh, Arata, Ortiz, Lorenzo, Kachapati, Kritika, Wu, Yuehong, Adams, David, Bednar, Kyle, Mukherjee, Shibabrata, Chougnet, Claire, Mittler, Robert S., Chen, Yi-Guang, Dolan, Laurence, Ridgway, William M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853870/ https://www.ncbi.nlm.nih.gov/pubmed/31787971 http://dx.doi.org/10.3389/fimmu.2019.02566

Ejemplares similares

Increased Soluble CD137 Levels and CD4+ T‐Cell‐Associated Expression of CD137 in Acute Atherothrombotic Stroke
por: He, Yang, et al.
Publicado: (2018)

Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies
por: Glez-Vaz, Javier, et al.
Publicado: (2022)

Lymphocyte Anergy in Patients with Carcinoma
por: Nind, A. P. P., et al.
Publicado: (1973)

Correction: Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies
Publicado: (2023)

Response: proliferative versus functional anergy
por: Charles, Edgar D., et al.
Publicado: (2011)

Anti–4-1bb Monoclonal Antibodies Abrogate T Cell–Dependent Humoral Immune Responses in Vivo through the Induction of Helper T Cell Anergy
por: Mittler, Robert S., et al.
Publicado: (1999)

Targeting innate immunity to downmodulate adaptive immunity and reverse type 1 diabetes
por: Itoh, Arata, et al.
Publicado: (2017)

GRAIL: a gene related to anergy in lymphocytes
por: Fathman, G, et al.
Publicado: (2003)

Hypoxia-induced soluble CD137 in malignant cells blocks CD137L-costimulation as an immune escape mechanism
por: Labiano, Sara, et al.
Publicado: (2014)

Soluble CD137 as a potential biomarker for severe COVID-19
por: Marques, Mariana de Oliveira, et al.
Publicado: (2022)

Role of Interleukin 12 and Costimulators in T Cell Anergy In Vivo
por: Parijs, Luk Van, et al.
Publicado: (1997)

Anergy and exhaustion are independent mechanisms of peripheral T cell tolerance
Publicado: (1995)

Models of T cell anergy: is there a common molecular mechanism?
Publicado: (1996)

Role of interleukin 12 and costimulators in T cell anergy in vivo
por: Van Parijs, Luk, et al.
Publicado: (2009)

Uncovering the mechanisms that regulate tumor-induced T-cell anergy
por: Abe, Brian T., et al.
Publicado: (2013)

Pulmonary Consequences of Prenatal Inflammatory Exposures: Clinical Perspective and Review of Basic Immunological Mechanisms
por: Jackson, Courtney M., et al.
Publicado: (2020)

Persistence of Peptide-induced CD4(+) T cell Anergy In Vitro
por: Ryan, Kelli R., et al.
Publicado: (1998)

Cutaneous anergy in pregnant and nonpregnant women with human immunodeficiency virus.
por: Eriksen, N L, et al.
Publicado: (1998)

Loss of the proapoptotic protein, Bim, breaks B cell anergy
por: Oliver, Paula M., et al.
Publicado: (2006)

Fully competent dendritic cells as inducers of T cell anergy in autoimmunity
por: Quaratino, S, et al.
Publicado: (2001)

Pregnancy imprints regulatory memory that sustains anergy to fetal antigen
por: Rowe, Jared H., et al.
Publicado: (2012)

A role for immunotherapy: preventing macrophage anergy in the tumour environment
por: Elia, Androulla, et al.
Publicado: (2013)

NK Cell Induced T Cell Anergy Depends on GRAIL Expression
por: Galazka, Grazyna, et al.
Publicado: (2019)

Cbl-b deficiency prevents functional but not phenotypic T cell anergy
por: Nguyen, Trang T.T., et al.
Publicado: (2021)

Membrane and Soluble CD137 in Systemic Lupus Erythematosus: Role as Biomarkers for Disease Activity
por: Ceccarelli, Fulvia, et al.
Publicado: (2023)

Clonal anergy of B cells: a flexible, reversible, and quantitative concept
Publicado: (1996)

Th2 cell clonal anergy as a consequence of partial activation
Publicado: (1994)

Positive and negative selection, self-nonself discrimination and the roles of costimulation and anergy
por: Mostardinha, P., et al.
Publicado: (2012)

Putting on the Brakes: Regulatory Kinases and Phosphatases Maintaining B Cell Anergy
por: Franks, S. Elizabeth, et al.
Publicado: (2018)

CD137-CD137 Ligand Interactions in Inflammation
por: Kwon, Byungsuk
Publicado: (2009)

Refractory T-Cell Anergy and Rapidly Fatal Progressive Multifocal Leukoencephalopathy After Prolonged CTLA4 Therapy
por: Dekeyser, Manon, et al.
Publicado: (2017)

Clinical implications of elevated serum soluble CD137 levels in patients with acute coronary syndrome
por: Yan, Jinchuan, et al.
Publicado: (2013)

Interleukin-10 plays an early role in generating virus-specific T cell anergy
por: Maris, Charles H, et al.
Publicado: (2007)

Anti-CD4 mediates clonal anergy during transplantation tolerance induction
Publicado: (1991)

CD4 T cells in murine acquired immunodeficiency syndrome: polyclonal progression to anergy
Publicado: (1992)

CD2 is involved in maintenance and reversal of human alloantigen- specific clonal anergy
Publicado: (1994)

Anergy and Cytokine-Mediated Suppression as Distinct Superantigen-Induced Tolerance Mechanisms in Vivo
por: Miller, Carla, et al.
Publicado: (1999)

CORRIGENDUM: Positive and negative selection, self-nonself discrimination and the roles of costimulation and anergy
por: Mostardinha, P., et al.
Publicado: (2013)

CD4(+) T cell anergy prevents autoimmunity and generates regulatory T cell precursors
por: Kalekar, Lokesh A., et al.
Publicado: (2016)

TNFR1 Signaling Contributes to T Cell Anergy During Staphylococcus aureus Sepsis
por: Ledo, Camila, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_89lmknl4o0uk7rsda7ut906msn